Context: Treatment and follow-up of patients thyroidectomized for differentiated thyroid
carcinoma (DTC) mainly depends on the identification of the patient's risk of recurrence …

Summary Objective Serum thyroglobulin (Tg) represents a highly specific biomarker for
detecting residual thyroid tissue/recurrence/metastases after treatment for differentiated …

Thyroglobulin (Tg) measurement is primarily used to monitor patients with differentiated
thyroid carcinoma (DTC) for tumor recurrence. Serum Tg levels principally integrate 3 …

English Differentiated thyroid cancer (DTC) is the most common endocrine cancer and its
incidence has increased in recent decades. Initial treatment usually consists of total …

Background In recent years serum thyroglobulin (Tg) measurement during thyroxine (T4)
treatment and/or after stimulation by endogenous TSH or recombinant human TSH (rhTSH) …

Determination of thyroglobulin (Tg) in serum represents a key element in the follow-up of
patients treated for differentiated thyroid cancer (DTC). The sensitivity and the specificity of …

It is worldwide recognized that circulating thyroglobulin (Tg) measurement represents a
fundamental tool in the follow-up of patients affected by differentiated thyroid cancer (DTC) …

Objective To evaluate a highly sensitive thyroglobulin (Tg) assay [functional sensitivity (FS):
0· 1 ng/ml](Tg‐ICMA) in low‐risk patients with known Tg on T4≤ 1 ng/ml measured by a …

Abstract Background: Serum thyroglobulin (Tg) is the marker of differentiated thyroid cancer
after initial treatment and TSH stimulation increases its sensitivity for the diagnosis of …

Summary objective To investigate to what extent thyroid remnant ablation and withdrawal
from thyroxine are required to achieve sufficient accuracy of serum thyroglobulin (Tg) …